Human muscle damage impairs insulin-signal transduction at the level of IRS-1, PI3-kinase and AKT-kinase: Potential role for TNF-alpha inhibition of insulin action in skeletal muscle

Physiological stress associated with muscle damage results in insulin resistance and an acute phase immune response, leading to mononuclear cell release of cytokines, including tumor necrosis factor (TNF)-α, interleukin (IL)-6 and IL-1β. We determined whether impaired insulin-signal transduction and...

Full description

Saved in:
Bibliographic Details
Main Author: Del Aguila, Luis F
Format: Dissertation
Language:English
Published: ProQuest Dissertations & Theses 01-01-1999
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Physiological stress associated with muscle damage results in insulin resistance and an acute phase immune response, leading to mononuclear cell release of cytokines, including tumor necrosis factor (TNF)-α, interleukin (IL)-6 and IL-1β. We determined whether impaired insulin-signal transduction and/or increased cytokine production play a role in muscle damage-induced insulin resistance. Muscle biopsies were obtained before (BASE) and at 1 h during a hyperinsulinemic-euglycemic clamp (INS) (40 mU·kg-1 ·min-1) in 8 young (age 24 ± 1 yr), healthy sedentary (VO2max = 49.7 ± 2.4 ml·kg-1·min -1) males before (CTRL) and 24 h after eccentric exercise-induced muscle damage (ECC). Venous blood samples were obtained before and 24 h after ECC to determine ex vivo endotoxin-induced mononuclear cell secretion of TNF-α, IL-6 and IL-1β. Glucose disposal was 19% lower after ECC (P < 0.05). Insulin-stimulated IRS-1 tyrosine phosphorylation was 45% lower after ECC (P < 0.05). Insulin-stimulated PI3-kinase, Akt serine phosphorylation and Akt-kinase activity were reduced 34, 65 and 20%, respectively after ECC (P < 0.05). TNF-α, but not IL-6 or IL-1β production, increased 2.4-fold 24 h after ECC (P < 0.05). TNF-α production was positively correlated with reduced insulin-action on PI3-kinase (r = 0.77, P = 0.04). To further determine the effects of TNF-α on insulin action in skeletal muscle, we measured IRS-1-associated PI3-kinase activity, the phosphorylation of two mitogen-activated protein kinases (MAPK, known as p42 MAPK and p44MAPK) and insulin stimulated 2-deoxyglucose (2DG) uptake in cultured C2C12 myotubes. We observed that TNF-α decreased insulin stimulation of IRS-1-associated PI3-kinase activity by 54% (P < 0.05), p42MAPK and p44 MAPK tyrosine phosphorylation by 81% (P < 0.01) and 2 DG uptake by 27% (P < 0.05). Okadaic acid, a phosphatase inhibitor, was used to determine the mechanisms by which TNF-α impairs insulin-signal transduction in C2C12 muscle cells. Okadaic acid blocked TNF-α repression of insulin-induced p42MAPK and p44MAPK tyrosine phosphorylation, suggesting a phosphatase-dependent mechanism in the inhibition of p42MAPK and p44MAPK by TNF-α. In contrast, TNF-α attenuation of IRS-1-associated PI3-kinase activity was not reversed by okadaic acid. In summary, the physiological stress associated with muscle damage impairs insulin-signal transduction and decreases insulin-mediated glucose uptake. Furthermore, elevated TNF-α production after muscle damage may impair insulin-signal transduction. The data from okadaic acid suggest that TNF-α impairs insulin stimulation of PI3-kinase activation and MAPK tyrosine phosphorylation through two different mechanisms.
ISBN:0599423765
9780599423763